This year, the Synaptic Dysfunction in Alzheimer Disease (SyDAD) project is coming to a close. It is a European training network funded by Marie Sklodowska Curie Actions under the EU-H2020 programme that supports 15 Early Stage Researchers (ESRs) and performs a collaborative research program to reveal the mechanisms behind synaptic dysfunction in Alzheimer’s disease (AD).
On 6 and 7 March, the SyDAD consortium met for a successful final meeting in Bordeaux (France). The meeting hosted by Professor Christophe Mulle and his team was attended by more than 40 participants including ESRs, their supervisors and partner organisations. SyDAD ESRs who are approaching the end of their PhD studies presented their respective work, progress and main achievements. They gave impressive presentations leading to fruitful discussions and scientific questions. In addition, attendees had very interesting reflections on the project’s training programme, out-reach activities, economy, innovation opportunities, research methods and upcoming deliverables. Professor Bengt Winblad (Coordinator) and Susanne Frykman (Project Manager) closed the final meeting by thanking all members for their hard work and scientific collaborations.
The ESRs are distributed in six organisations including Karolinska Institutet (Stockholm, Sweden), University of Bordeaux (Bordeaux, France), University of Milano (Milano, Italy), Deutsches Zentrum für Neurodegenerative Erkrankungen (Bonn, Germany), Janssen Pharmaceutica NV (Beerse, Belgium) and Axon Neuroscience (Bratislava, Slovakia). Alzheimer Europe (AE) is a partner organisation in this project. Cindy Birck, AE Project Officer attended the meeting.